Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Merit Medical Systems Inc.

Merit Medical (($MMSI)) has held its Q1 earnings call. Read on for the main highlights of the call. Merit Medical’s latest earnings call struck an ...

Merit Medical Earnings Call Highlights Growth Amid Headwinds

In a report released today, Jason Bednar from Piper Sandler reiterated a Buy rating on Merit Medical Systems, with a price target of $96.00. Bednar...

Piper Sandler Sticks to Their Buy Rating for Merit Medical Systems (MMSI)

Merit Medical (MMSI) has disclosed a new risk, in the Corporate Activity and Growth category. Merit Medical’s amended executive employment and equi...

Merit Medical’s Revised Executive Pay Deals Raise Dilution, Governance and M&A Flexibility Concerns

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merit Medical Systems (MMSI), Alterity Therapeutics (ATHE) and Mo...

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Alterity Therapeutics (ATHE) and Moderna (MRNA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Dexcom (DXCM) and Merit Medical Syst...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merit Medical Systems (MMSI)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Option Care Health (OPCH), Merit Medical Systems (MM...

Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Merit Medical Systems (MMSI) and OrthoPediatrics (KIDS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Irhythm Technologies (IRTC), Pacira Pharmaceuticals ...

Analysts Are Bullish on Top Healthcare Stocks: Irhythm Technologies (IRTC), Pacira Pharmaceuticals (PCRX)

Merit Medical Systems ( ($MMSI) ) has shared an update. On April 30, 2026, Merit Medical reported first-quarter 2026 results that beat its own expe...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MMSI	$64.52	+0.55%	713.29K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MMSI	$64.52	+0.5%	713.29K
3
4
5
6

MMSI

MMSI

No Data Available

Get Merit Medical Systems Inc. Data in Excel

Get Merit Medical Systems Inc. Data in Excel